The urokinase-type plasminogen activator (uPA) plays a central role in liver repair. Nevertheless, the hepatic overexpression of uPA results in panlobular injury and neonatal mortality. Here, we define the molecular mechanisms of liver injury and explore whether uPA can regulate liver repair independently of plasminogen. To address the hypothesis that the liver injury in transgenic mice results from the intracellular activation of plasminogen by transgene-derived uPA (uPAT), we generated mice that overexpress uPAT and lack functional plasminogen (uPAT-Plg o ). In these mice, loss of plasminogen abolished the hepatocyte-specific injury and prevented the 
INTRODUCTION
The reparative response to an injury requires intact cellular proliferation and coordinated tissue remodeling. Shortly after injury, proliferation of undifferentiated and mature cells promptly increases to repopulate the injured tissue and later undergoes downregulation to prevent overgrowth and neoplasia. Meanwhile, tissue remodeling demands restructuring of the extracellular matrix (ECM) to restore the architectural organization of the healthy tissue. In the liver, remodeling is directed by the combined forces of multiple cell-associated and extracellular proteases. Among serine proteases, plasminogen and plasminogen activators play a central role in liver repair after acute injury. In the absence of plasminogen or plasminogen activators, clearance of necrotic cell debris and matrix components is severely impaired, resulting in defective repair after an acute or a chronic injury (3, 4, 17, 19) .
The plasminogen system includes the inactive proenzyme plasminogen (Plg) which is proteolytically converted to the active serine protease, plasmin, by either urokinase-type plasminogen activator (uPA) or tissue-type plasminogen activator (tPA).
In addition to the traditional role in vascular hemostasis, plasmin and plasminogen activators regulate several biologic processes involving proteolysis of the ECM, such as tissue remodeling, inflammation, tumor invasion, and metastasis (1, 2, 8, 9, 26) .
Although many of these processes are supported by plasmin-mediated fibrinolysis (6, 7) , the defective remodeling of livers of mice lacking plasminogen is independent of 4 fibrin deposition (3) . An impairment in liver remodeling that is qualitatively similar is also produced when mice lack uPA or both uPA and tPA, but not tPA alone (4) .
Despite the key role of uPA in promoting liver repair, hepatic overexpression of uPA in transgenic mice causes severe liver injury with an early onset (12) . Notably, the injury is specific to hepatocytes and is panlobular, leading to decreased survival of transgenic mice in the first few days after birth. In this paper, we explore the molecular mechanism(s) mediating these seemingly opposing effects of uPA in the liver. Based on the role of uPA as an activator of plasminogen, we hypothesized that the liver injury in transgenic mice is caused by the co-expression of uPA and Plg within hepatocytes. To address this hypothesis, we generated mutant mice that simultaneously express the uPA transgene and are homozygous for a null allele in the endogenous plasminogen gene. We report that the loss of plasminogen completely abolishes liver injury in mutant mice. Furthermore, by challenging these mice with a hepatotoxin, we demonstrate that the overproduction of uPA does not correct the defective remodeling in plasminogen deficient mice following acute liver injury. Together these data demonstrate that plasminogen mediates the pleiotropic effects of uPA in liver injury and repair.
MATERIAL AND METHODS
Reagents. Liver samples were fixed in 10% formalin from Accra Laboratory (Cleveland, OH), and hepatocyte proliferation was detected using the Cell Proliferation Kit obtained 
Transgenic and gene-targeted mice. Heterozygous transgenic mice with albumin
promoter/enhancer-driven overexpression of a uPA transgene (uPAT) were obtained from Jackson Laboratories (Bar Harbor, ME) (12) . To generate mice overexpressing uPAT without plasminogen (uPAT-Plg°), we mated uPAT mice with mice carrying the targeted inactivation of the plasminogen gene (Plg°). Mice with a targeted disruption of the gene coding for plasminogen were of a mixed 129 SvJ/CF-1/NIH Black Swiss background (6, 7). Offspring were genotyped by PCR using specific primers for endogenous and targeted alleles for Plg and the uPA transgene using tail biopsy DNA as the template (7, 13) . Mice of all genotypes were housed in standard facilities and fed food and water ad libitum. Survival analysis was performed by examining and weighing mice weekly for the entire duration of the study (58 weeks). Animal protocols were In order to induce acute liver injury, uPAT, Plg°, uPAT-Plg° mice and control littermates were given an intraperitoneal injection of 0.05 ml carbon tetrachloride (CCl 4 ) per 100g of body weight as a 25% solution in corn oil at 2 months of age (27) . At 2, 7 and 14 days after CCl 4 , mice were weighed and anesthetized, and blood samples were collected as described above. The anterior lobe of the liver was collected, fixed and 7 stained with hematoxylin and eosin also as described above. Immunohistochemical analysis of fibrinogen was done in paraffin-embedded liver sections using rabbit antifibrinogen antiserum, the Vectastain ABC-AP detection system (Vector Laboratories, Burlingame, CA), and Fast Red TR/Napthol AS-MX (Sigma Chemical Co., St. Louis, MO) to detect alkaline phosphatase activity in situ, as described previously (3).
Northern Blot Analysis. Total RNA was isolated from frozen liver tissue using Trizol Reagent and the expression of the uPA transgene and plasminogen was determined as described previously (10, 12, 13) . Northern blots were hybridized with 32 P-labeled cDNA probes for the uPA transgene and plasminogen simultaneously. Specific signal was quantified using phosphor screens and an ImageQuant phosphoimager.
Zymographic analysis of Plasminogen Activator.
Liver protein extracts were obtained from frozen liver tissue homogenized in buffer containing phosphate buffered saline (137 mM NaCl, 2.7 mM KCl, 4.3 mM Na 2 HPO 4 ⋅7H 2 O, 1.4 mM KH 2 PO 4 ), 1% Nonidet P-40, 0.5% deoxycholate, 0.1% sodium dodecyl sulfate (SDS), and 10% protease inhibitor cocktail (Calbiochem, La Jolla, CA). Homogenates were centrifuged at 12,000 x g for 15 min at 4°C, and protein concentrations in liver lysates were measured using the Bradford Method-based BioRad Assay. Plasma was obtained from the supernatants of heparinized blood samples following centrifugation at 9000 rpm. Liver protein extracts (3.0 µg) and plasma samples (0.1 µl) were solubilized in non-reducing buffer and electrophoresed on SDS-polyacrylamide gel cast with 8% casein and 20 µg/ml plasminogen as described previously (12). 
RESULTS

Plasminogen deficiency prevents urokinase-induced liver injury. The albumin
promoter/enhancer-driven overexpression of the uPA transgene causes liver injury that is apparent immediately after birth, which increases neonatal mortality (12) . In normal mice, endogenous uPA production in the liver is low and is derived from nonparenchymal cells while plasminogen is expressed primarily by hepatocytes (28) . To determine whether plasminogen activation by the uPA transgene within hepatocytes is 9 the mechanism of injury in transgenic mice, we mated uPAT mice with Plg° mice. Visual inspection of livers from littermates revealed the typical pale, white appearance of uPAT livers at 3 weeks of age, followed by the formation of regenerative nodules, which gradually expanded and repopulated the entire liver after 8 weeks of age (Fig. 1A) . In contrast, livers of uPAT-Plg° mice appeared normal and indistinguishable from Plg°m ice and control littermates. To demonstrate that normal-appearing livers of uPAT-Plg°m ice had expression of the uPA transgene, we used incubated Northern blots containing liver RNA from littermates with radiolabeled cDNA probes for plasminogen and uPAT transgene simultaneously. Using this approach, we documented ongoing expression of the uPA transgene in normal appearing livers of uPAT-Plg° mice (Fig.   1B) . Consistent with the absence of injury, livers of uPAT-Plg° mice never developed regenerative nodules and displayed a normal appearance through adult life, suggesting that plasminogen deficiency prevented hepatotoxicity induced by the uPA transgene.
To determine whether plasminogen deficiency completely abolishes the hepatocyte-specific injury in uPAT mice, we carried out microscopic analyses of liver sections from uPAT-Plg° mice and uPAT littermates. Hematoxylin and eosin staining of uPAT-Plg° livers revealed that plasminogen deficiency prevented the development of the panlobular injury typically seen in uPAT livers, as demonstrated by normal histological appearance at 3 and 8 weeks and 7 months of age (Fig. 2) . In contrast, uPAT livers had easily identifiable hepatocyte injury at 3 weeks of age and regenerative nodules surrounded by injured hepatocytes (Fig. 2) . Cytoplasmic vacuolization and small nuclei were seen in hepatocytes of uPAT livers, while all other neighboring nonparenchymal cells appeared normal. At the ultrastructural level, electron microscopic analysis revealed that urokinase overexpression resulted in the accumulation of vacuoles and multivesicular bodies surrounded by fragmented rough endoplasmic reticulum in mice with normal levels of plasminogen expression; such findings were completely absent in livers of uPAT-Plg° mice (Fig. 3) (25) . (Fig. 4) . At 7 and 14 days, the injury resolved and the lobular organization was restored in normal and uPAT littermates. Although uPAT mice had some residual areas of transgene-induced injury, the additional toxic insult by CCl 4 did not increase mortality or influence the ability of the liver to undergo a timely repair. More notable was the severe impairment in repair of livers from uPAT-Plg° mice at 7 and 14 days, which displayed poor removal of necrotic cell debris and defective lobular organization. The appearance and extent of the centrilobular injury was similar in the livers of all uPAT and uPAT-Plg° mice at 7 and 14 days. uPA overexpression in uPAT-Plg° mice did not influence liver function or the onset/degree of injury (indicated by similar plasma levels of albumin and ALT in uPAT and uPAT-Plg o mice at different time points -data not shown). Notably, the BrdUlabeling of hepatocytes was <0.5% for all genotypes before injection with CCl 4 , dramatically increased at 2 days after CCl 4 in a similar fashion in all groups, and returned to low baseline levels at 7 and 14 days (Fig. 5 ).
In view of the persistent centrilobular injury and of the well-established role of uPA and plasminogen in fibrinolysis, we next determined the ability of uPAT-Plg° mice to clear fibrin from injured livers. We found a remarkable accumulation of fibrin within injured centrilobular areas at 2 days in mice of all genotypes, followed by effective fibrin clearance in livers of Plg + and uPAT mice ( fig. 6 ) at days 7 and 14 (Fig. 6) . The fibrin clearance, however, was severely impaired in livers of Plg° and uPAT-Plg° mice as evidenced by intense fibrin immunostaining in areas of centrilobular injury throughout the duration of the study. Taken together, these data demonstrate that uPA overexpression does not overcome the defect in liver repair produced by plasminogen deficiency.
uPA overexpression does not correct extra-hepatic consequences of plasminogen deficiency. We next explored whether uPA overexpression partially or completely corrects the extra-hepatic phenotype displayed by plasminogen-deficient mice by examining littermates weekly and recording survival in littermates up to 17 months of age. We found that long-term survival among the uPAT-Plg° and Plg° mice decreased significantly compared to Plg + and uPAT littermates (P < 0.01), with no uPAT-Plg° mice surviving beyond 13.2 months (Fig. 7) . There was no significant difference in the survival rate between Plg° and uPAT-Plg° mice. Furthermore, we found the extra-hepatic manifestations of plasminogen deficiency in Plg° mice (rectal bleeding, rectal and penile prolapse and wasting) in >90% of uPAT/Plg° mice which became obvious by 10 months of age (6) . These data demonstrate that the overexpression of uPA does not reverse the extra-hepatic effects of plasminogen deficiency. Timely cellular proliferation is central to the regenerative response of the liver to an injury. Following partial hepatectomy, hepatocytes and non-parenchymal cells of liver remnants undergo well orchestrated rounds of proliferation to restore liver mass (11, 16) . Using this experimental model, uPA has been shown to be needed for the prompt entry of hepatocytes into the cell cycle, but there appear to be alternative mechanisms to gradually restore liver mass and maintain survival in the absence of uPA (23) .
DISCUSSION
Despite the apparent role of uPA as a facilitator of hepatocyte proliferation after partial hepatectomy (23), we previously found that following a toxic injury induced by CCl 4 , uPA deficiency had no detrimental effect on hepatocyte proliferation; instead, removal of 4K=x4,000; 20K=x20,000). in mice of all genotypes, followed by a return to baseline levels within 7-14 days (N=4-6
for each genotype at each time point; P>0.05 for statistical comparison among subjects within each time point). 
